	AI-Based Noninvasive Pain Detection in Alzheimer's Patients Using Facial Micro-Expression Analysis. Proc Int Conf Adv Inf Netw Appl Brown E, Lu A, Lu W. PMID: 42688956 [PubMed]
	Shared Metabolic-Proteinopathy Axis in Alzheimer's Disease and Parkinson's Disease: Evidence for a Convergent but Not Identical Disease Spectrum. Aging Med (Milton) Yao SY, Du MQ, Lin LX, Kang XH, Jiang DY, Peng Y. PMID: 42688951 [PubMed - as supplied by publisher]
	Nicotinic Acetylcholine Receptor Modulation Distinguishes Clinical Benefits of Galantamine in Alzheimer's Disease. Sage Open Aging Svintozelskiy PV, Wahlert AJ, Harrod C, Kay DG, Grady KP, Grossberg GT. PMID: 42688663 [PubMed]
	Bridging language markers and pathology: correlations between digital speech measures and surrogate CSF biomarkers in Alzheimer's disease. Alzheimers Dement (Amst) Pang Y, Chen L, Dodge HH, Zhou J. PMID: 42688514 [PubMed]
	Anti-amyloid treatment in Alzheimer disease: updated implications for patients with cerebral amyloid angiopathy and other cerebrovascular conditions. Front Neurol Zupan M, Prelog PR, Kramberger MG, Frol S. PMID: 42688139 [PubMed - indexed for MEDLINE]
	Multi-omics integration identifies a gut-microbiota-associated plasma metabolite signature for alzheimer disease diagnosis and metabolic pathway targeting. Front Pharmacol Chen J, Chen X, Yu W, Chen T, Liu Z, Hu J. PMID: 42688072 [PubMed]
	Temporal trends in the prevalence of Alzheimer's disease, 1980-2024: a systematic review and meta-analysis. Front Public Health Hu M, Sun Z, Mao D, Tian X, Shang Q. PMID: 42688049 [PubMed - indexed for MEDLINE]
	Association between Internet Use for Health Information and Self-reported Alzheimer's Disease Diagnosis among Older Adults in the United States: Racial and Gender Disparities. Res Sq Zeidan HM, Shah GH, Zeidan IH, Samawi HM, Jones JA. PMID: 42687965 [PubMed]
	Acitretin shows promising potential in Alzheimer's disease: retinoid-driven modulation of amyloid processing, neuroinflammation, and translational prospects. Inflammopharmacology Sharma V, Vashisht K, Choudhary G, Choudhay V, Bhatia V, Ashawat MS, Baldi A, Kushawaha SK. PMID: 42686974 [PubMed - as supplied by publisher]
	Memory, social cognition, and beyond: Neuropsychological markers differentiating Alzheimer's disease and frontotemporal dementia. J Alzheimers Dis Freitag JM, Konen FF, Heck J, Jahn K, Groba S, Klietz M, Skripuletz T, Wegner F, Schulze Westhoff M, Schröder S. PMID: 42684971 [PubMed - as supplied by publisher]
	Toward harmonized reporting of Alzheimer's disease biomarkers in clinical practice. Clin Chem Lab Med Agnello L, Pilotto A, Gaetani L, Bellomo G, Bessi V, Bozzali M, Cagnin A, Labate A, Massa F, Moda F, Monastero R, Musso G, Piccoli T, Sancesario G, Parnetti L, Padovani A, Ciaccio M. PMID: 42683894 [PubMed - as supplied by publisher]
	Stage-Dependent Cognitive Effects of a Multinutrient Intervention in Alzheimer's Disease: A Stage-Stratified Meta-Analysis. J Vis Exp Han P, Dong P, Zhou Y, Zhang L, Mahomed O. PMID: 42683892 [PubMed - indexed for MEDLINE]
	A world view: Considerations of sociocultural diversity in the study of subjective cognitive decline in Alzheimer's disease and related dementias. Alzheimers Dement Dubbelman MA, Hill-Jarrett TG, Chapman S, Alves Andrade Dos Santos G, Azar M, Babulal GM, Bell TR, Bernard MA, Boza-Calvo C, Briggs AQ, Bubu OM, Cuevas HE, Dowling NM, Esiaka DK, Fausto BA, de Oliveira FF, Franz CE, Furlano JA, Gonzalez-Corona C, Guest MA, Gupta VB, Gupta VK, Jackson D, Joyce JL, Kann MR, Kremen WS, Lee A, Martinez JE, Masurkar AV, McLin MA, Resende EPF, Rahemi Z, Renfro BC, Aliberti MJR, Shagalow S, Slachevsky A, Talarico JNS, Trani JF, Van Hulle C, Waltrip L, Wandera SO, Windon CC, Yassuda MS, Moretti DV, Kuhn E, Butterbrod E, Gifford KA, Sikkes SAM, Castilhos RM, Nosheny R, Stites SD, a collaboration of the Alzheimer's Association International Society to Advance Alzheimer's Research and Therapy Subjective Cognitive Decline and Diversity and Disparities Professional Interest Areas. PMID: 42683545 [PubMed - indexed for MEDLINE]
	The highest clinical trial failure rate for any disease in modern medicine: How both amyloid- and non-amyloid-targeting therapies failed to alter disease course in Alzheimer's disease. Free Neuropathol Guth MAS. PMID: 42683436 [PubMed]
	From amyloid PET to plasma biomarkers: A multimodal imaging framework for early diagnosis and staging of Alzheimer's disease. Alzheimers Dement (Amst) Liu J, Xu C, Wang Y, Zhang J, Hui R, Lv W, Xu A, Dang Y, Su S, Zhao H, Gao Y, Zhang J. PMID: 42683384 [PubMed]
	Aquaporin dysfunction and impaired brain interstitial fluid clearance in Alzheimer's disease - an integrative review. Front Cell Neurosci Manescu MD, Minca T, Pirici I, Busuioc CJ, Mateescu VO, Pirici D. PMID: 42683218 [PubMed]
	Comment on "The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs". Int J Surg Han J, Wang M, Wu Z. PMID: 42682345 [PubMed]
	Proteome-wide genetic study identified therapeutic targets for early-onset and late-onset Alzheimer's disease. Int J Surg Chen L, Sun H, Fang MJ, Cheng N, Xu Y. PMID: 42682321 [PubMed]
	Brain-Targeting siRNA Delivery to Tackle Alzheimer's Disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol Yang Q, Chen Z, Zhu J, Chai T, Tang F, Fan M, Li Y, Chen S, Liu Y, Zheng M. PMID: 42682011 [PubMed - indexed for MEDLINE]
	Curcumin nanoformulations for modulating neuroinflammation and oxidative stress in Alzheimer's disease: blood-brain barrier transport, formulation strategies and therapeutic applications. Inflammopharmacology Begum MY, Rajkumar M, Govindaraj P, Prathap N, Sudha PN, Al Hamod M, Alotaibi H, Uvarajan D. PMID: 42680958 [PubMed - as supplied by publisher]

Articles 1 - 20 / 72073

Page 1 of 3604



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy